Advertisement

Advertisement

AEON Stock Latest News

Aeon Biopharma designates Paul Lee as acting chief regulatory officer

The FlyAeon Biopharma designates Paul Lee as acting chief regulatory officer

Aeon Biopharma price target lowered to $1.20 from $5 at H.C. Wainwright

PremiumThe Fly

Aeon Biopharma price target lowered to $1.20 from $5 at H.C. Wainwright

11d ago

AEON Biopharma Reports Q2 Results, Advances ABP-450 Program

PremiumCompany Announcements

AEON Biopharma Reports Q2 Results, Advances ABP-450 Program

15d ago

AEON Biopharma Regains NYSE American Listing Compliance

PremiumCompany Announcements

AEON Biopharma Regains NYSE American Listing Compliance

24d ago

Humana upgraded, Las Vegas Sands downgraded: Wall Street’s top analyst calls

PremiumThe Fly

Humana upgraded, Las Vegas Sands downgraded: Wall Street’s top analyst calls

28d ago

Lake Street starts Aeon Biopharma at Buy on potential of Botox competitor

PremiumThe FlyLake Street starts Aeon Biopharma at Buy on potential of Botox competitor

28d ago

Aeon Biopharma initiated with a Buy at Lake Street

The Fly

Aeon Biopharma initiated with a Buy at Lake Street

28d ago

AEON Biopharma boosts liquidity with additional share sale

Company Announcements

AEON Biopharma boosts liquidity with additional share sale

1M ago

Aeon announces pricing of upsized $13.75M public offering

PremiumThe Fly

Aeon announces pricing of upsized $13.75M public offering

1M ago

AEON Biopharma shareholders approve directors and auditor slate

PremiumCompany Announcements

AEON Biopharma shareholders approve directors and auditor slate

2M ago

AEON Biopharma Releases Updated Investor Relations Presentation

PremiumCompany Announcements

AEON Biopharma Releases Updated Investor Relations Presentation

3M ago

Aeon Biopharma management to meet virtually with Lake Street

PremiumThe Fly

Aeon Biopharma management to meet virtually with Lake Street

3M ago

Aeon receives additional notice related to NYSE American listing standards

PremiumThe FlyAeon receives additional notice related to NYSE American listing standards

5M ago

AEON Biopharma Receives Additional NYSE American Noncompliance Notice

Company Announcements

AEON Biopharma Receives Additional NYSE American Noncompliance Notice

5M ago

Is AEON a Buy, Before Earnings?

Pre-Earnings

Is AEON a Buy, Before Earnings?

5M ago

Aeon Biopharma announces FDA feedback after Type 2a meeting

PremiumThe Fly

Aeon Biopharma announces FDA feedback after Type 2a meeting

5M ago

Aeon Biopharma appoints John Bencich as CFO

PremiumThe Fly

Aeon Biopharma appoints John Bencich as CFO

6M ago

AEON Biopharma Strengthens Finance Leadership with New CFO

PremiumCompany Announcements

AEON Biopharma Strengthens Finance Leadership with New CFO

6M ago

Aeon Biopharma files to sell 51.29M shares of Class A common stock for holders

PremiumThe Fly

Aeon Biopharma files to sell 51.29M shares of Class A common stock for holders

7M ago

AEON Biopharma Advances Biosimilar Program and Debt Reduction

PremiumCompany AnnouncementsAEON Biopharma Advances Biosimilar Program and Debt Reduction

7M ago

Aeon Biopharma reports BPD Type 2a meeting with FDA

The Fly

Aeon Biopharma reports BPD Type 2a meeting with FDA

7M ago

AEON Biopharma Releases Updated Investor Presentation Under Reg FD

Company Announcements

AEON Biopharma Releases Updated Investor Presentation Under Reg FD

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >